Therefore, therapies that alter the levels/ratio of these adipokines or act to increase the expression of the AdipoR1 may represent interventions that can alter tumor growth microenvironment, increasing the chance of success in obese breast cancer patients regardless of menopausal status. Here, ADIPOR1 is linked to breast cancer.